FDA Approves DOXYCYCLINE HYCLATE — Alembic Pharmaceuticals Limited

# FDA Approves Alembic Pharmaceuticals' Doxycycline Hyclate Generic Alembic Pharmaceuticals Limited has received FDA approval for its generic doxycycline hyclate oral formulation, expanding the competitive landscape for this widely-used antibiotic and potentially exerting downward pricing pressure in a mature generic market. The approval is expected to provide healthcare providers and patients with an additional cost-effective treatment option for bacterial infections.